Food and Drug Administration
COVID-19, Mobile Health & the Importance of Maintaining Legal Compliance in an Era of Explosive Growth
Nov 18, 2020 at 02:02 pm by Staff
Renee Rayne
Mobile health apps have become quite commonplace and are projected to continue rapid growth to become a $57.57 billion market by 2026. Although COVID-19 has create.... Read More
FDA Asks Endo Pharma to Pull Opana ER
Jun 09, 2017 at 11:42 am by Staff
In a highly unusual move, the U.S. Food and Drug Administration has requested Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydroc.... Read More